Clinical trial
Study of Sivelestat Sodium Hydrate in Acute Lung Injury (ALI) Associated With…
NCT00219375 · Ono Pharmaceutical Co. Ltd, Industry · Completed
Key facts
| NCT number | NCT00219375 |
|---|---|
| Title | Study of Sivelestat Sodium Hydrate in Acute Lung Injury (ALI) Associated With Systemic Inflammatory Response Syndrome (SIRS) in Japan |
| Official title | Efficacy and Safety of Sivelestat Sodium Hydrate in Acute Lung Injury Associated With Systemic Inflammatory Response Syndrome, Compared With the Conventional Treatment in Japan |
| Lead sponsor | Ono Pharmaceutical Co. Ltd, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Acute Lung Injury, Systemic Inflammatory Response Syndrome |
| Intervention type | Drug |
| Interventions | Sivelestat sodium hydrate |
| Enrollment | 649 |
| Start date | Jun 1, 2004 |
| Primary completion | Jul 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Apr 23, 2015 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: